Shopping Cart
Remove All
Your shopping cart is currently empty
BChE/MAO-B-IN-2 is a dual inhibitor with excellent blood-brain barrier permeability, targeting BChE (IC50 = 0.05 μM, Ki = 0.01 μM) and MAO-B (IC50 = 0.45 μM, Ki = 0.08 μM). It exhibits antioxidant properties, including DPPH radical scavenging, CUPRAC copper ion reduction, and superoxide anion scavenging. BChE/MAO-B-IN-2 is applicable in Alzheimer's disease (AD) research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | BChE/MAO-B-IN-2 is a dual inhibitor with excellent blood-brain barrier permeability, targeting BChE (IC50 = 0.05 μM, Ki = 0.01 μM) and MAO-B (IC50 = 0.45 μM, Ki = 0.08 μM). It exhibits antioxidant properties, including DPPH radical scavenging, CUPRAC copper ion reduction, and superoxide anion scavenging. BChE/MAO-B-IN-2 is applicable in Alzheimer's disease (AD) research. |
| Targets&IC50 | MAO-B:0.45 μM |
| In vitro | BChE/MAO-B-IN-2 (Compound 4a-S) demonstrates DPPH radical scavenging activity with an IC50 of 3.57 mM, exhibits antioxidant activity in the CUPRAC assay with an IC50 of 33 μM, and possesses superoxide anion scavenging capability with an IC50 of 24 μM. Furthermore, MAO-B-IN-48 (1-25 μM) is non-cytotoxic to HepG2 cells. |
| In vivo | Administering BChE/MAO-B-IN-2 (20 mg/kg, oral gavage, for one week) can alleviate cognitive dysfunction induced by AlCl3 in mice. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.